Melanoma Institute Australia, The University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW 2050, Australia.
JAMA Dermatol. 2013 Jun;149(6):692-8. doi: 10.1001/jamadermatol.2013.2301.
Lentigo maligna (LM) is a clinical, pathologic, and therapeutic challenge with a higher risk of local recurrence than other types of melanoma correctly treated and also carries the cosmetically sensitive localization of head and neck.
To determine whether in vivo reflectance confocal microscopy (RCM) mapping of difficult LM cases might alter patient care and management.
Analysis of LM and LM melanoma (LMM) in a series of patients with large facial lesions requiring complex reconstructive surgery and/or recurrent or poorly delineated lesions at any body sites were investigated.
Two tertiary referral melanoma centers in Sydney, Australia.
Thirty-seven patients with LM (including 5 with LMM) were mapped with RCM. Fifteen patients had a recurrent LM, including 9 with multiple prior recurrences. The LM was classified amelanotic in 10 patients, lightly pigmented in 9, and partially pigmented in 18.
The RCM images were obtained in 4 radial directions (allowing for anatomic barriers) for LM margin delineation using an RCM LM score previously described by our research team.
Differences in the margin of LM as determined by RCM vs dermoscopy vs histopathologic analysis.
Seventeen of 29 patients (59%) with dermoscopically visible lesions had subclinical (RCM-identified) disease evident more than 5 mm beyond the dermoscopy margin (ie, beyond the excision margin recommended in published guidelines). The RCM mapping changed the management in 27 patients (73%): 11 patients had a major change in their surgical procedure, and 16 were offered radiotherapy or imiquimod treatment as a consequence of the RCM findings. Treatment was surgical in 17 of 37 patients. Surgical excision margins (based on the RCM mapping) were histopathologically involved in only 2 patients, each of whom had an LM lesion larger than 6 cm.
In vivo RCM can provide valuable information facilitating optimal patient care management.
恶性雀斑样痣(LM)是一种临床、病理和治疗上的挑战,其局部复发风险高于其他类型的黑色素瘤,并且位于头颈部,美容要求高。
确定活体反射共聚焦显微镜(RCM)对困难 LM 病例的成像是否会改变患者的治疗和管理。
分析一系列面部大皮损患者的 LM 和 LM 黑色素瘤(LMM),这些患者需要复杂的重建手术,或有任何部位的复发性或边界不清的病变。
澳大利亚悉尼的两个三级转诊黑色素瘤中心。
37 例 LM(包括 5 例 LMM)患者接受了 RCM 成像。15 例患者 LM 复发,其中 9 例有多次复发。10 例 LM 为无色素型,9 例为轻度色素型,18 例为部分色素型。
使用我们研究团队之前描述的 RCM LM 评分,在 4 个放射方向上获得 LM 边界的 RCM 图像,以进行 LM 边界描绘。
RCM 与皮肤镜与组织病理学分析相比,在 LM 边界上的差异。
29 例有皮肤镜可见病变的患者中,17 例(59%)有亚临床(RCM 识别)疾病,其病变范围超过皮肤镜边界 5mm 以上(即超过发表指南推荐的切除边界)。RCM 成像改变了 27 例患者(73%)的治疗方案:11 例患者的手术方式发生了重大改变,16 例患者因 RCM 结果而接受放疗或咪喹莫特治疗。37 例患者中有 17 例接受了手术治疗。只有 2 例患者的手术切除边缘(基于 RCM 成像)在组织病理学上受累,这 2 例患者的 LM 病变均大于 6cm。
活体 RCM 可以提供有价值的信息,有助于优化患者的治疗管理。